EP1747001
Stjórnun á gegnblæðingum í útvíkkuðum meðferðaráætlunum hormónagetnaðarvarna
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
29.4.2005EP published:
10.10.2018EP application number:
05740127.5
EP translation filed:
9.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
28.4.2025Expiry date:
28.4.2025
Title:
MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS
Timeline
Today
29.4.2005EP application
10.10.2018EP Publication
9.1.2019Translation submitted
15.2.2019Registration published
28.4.2025Expires
Owner
Name:
Bayer Intellectual Property GmbHAddress:
Alfred-Nobel-Strasse 50, 40789, Monheim am Rhein, DE
Inventor
Name:
SACHSE, AndreasAddress:
Berlin, DE
Name:
SULAK, Patricia J.Address:
Temple, TX, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
566443 PDate:
30.4.2004Country:
US
Number:
575024 PDate:
28.5.2004Country:
US
Number:
577199 PDate:
7.6.2004Country:
US
Number:
638380 PDate:
27.12.2004Country:
US
Number:
660068 PDate:
10.3.2005Country:
US
Classification
Categories:
A61K 31/565, A61K 31/57, A61K 31/567, A61K 31/575, A61K 31/585, A61P 15/18, A61K 31/56
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 26.3.2019
Expires: 28.4.2020
Payer: Árnason Faktor
Number: 16
Paid: 26.3.2020
Expires: 28.4.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 29.3.2021
Expires: 28.4.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 23.3.2022
Expires: 28.4.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 25.3.2023
Expires: 28.4.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 26.3.2024
Expires: 28.4.2025
Payer: Árnason Faktor ehf.